Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety-Reference-Cited by-同舟云学术

Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety

Published:2021-03-23 Issue:7 Volume:30 Page:843-857
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Duszynski Katherine M.¹^ORCID,Stark James H.²^ORCID,Cohet Catherine³^ORCID,Huang Wan‐Ting⁴^ORCID,Shin Ju‐Young⁵^ORCID,Lai Edward Chia‐Cheng⁶^ORCID,Man Kenneth K. C.⁷⁸^ORCID,Choi Nam‐Kyong⁹,Khromava Alena¹⁰^ORCID,Kimura Tomomi¹¹^ORCID,Huang Kui¹²^ORCID,Watcharathanakij Sawaeng¹³,Kochhar Sonali¹⁴¹⁵^ORCID,Chen Robert T.¹⁶^ORCID,Pratt Nicole L.¹^ORCID

Affiliation:

1. Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences University of South Australia Adelaide South Australia Australia

2. Vaccine Medical, Scientific and Clinical Affairs Pfizer Inc. New York New York USA

3. Vaccines Clinical Research & Development GlaxoSmithKline Wavre Belgium

4. Office of Preventive Medicine Taiwan Centers for Disease Control Taipei Taiwan

5. School of Pharmacy Sungkyunkwan University Suwon South Korea

6. School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine National Cheng Kung University Tainan Taiwan

7. Research Department of Practice and Policy UCL School of Pharmacy London UK

8. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy The University of Hong Kong Hong Kong

9. Department of Health Convergence Ewha Womans University Seoul South Korea

10. Epidemiology and Benefit Risk, Sanofi Pasteur Ltd. Toronto Ontario Canada

11. Astellas Pharma Inc. Northbrook Illinois USA

12. Global Medical Epidemiology Worldwide Medical and Safety, Pfizer Inc., New York New York United States of America

13. Faculty of Pharmaceutical Sciences Ubon Ratchathani University Ubon Ratchathani Thailand

14. Global Healthcare Consulting New Delhi India

15. Department of Global Health University of Washington Seattle Washington USA

16. Brighton Collaboration The Task Force for Global Health Decatur Georgia USA

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5214

Reference72 articles.

1. Planning for COVID-19 vaccines safety surveillance

2. Optimizing safety surveillance for COVID-19 vaccines

3. Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study

4. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study

5. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Practice and Considerations for Real‐World Data Source Identification and Feasibility Assessment;Pharmacoepidemiology and Drug Safety;2024-08-30

2. A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case;Pharmacoepidemiology and Drug Safety;2023-06-15

3. Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study;Vaccine;2022-10

4. A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol;Frontiers in Pharmacology;2022-07-13

5. Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design;Frontiers in Pharmacology;2022-03-22